Comments
Shares of Biocon will remain in focus next week, as the public issue of its arm Syngene International will open for subscription between July 27 and 29. The company has fixed the price band at ₹240-250 a share and plans to raise ₹550 crore through the issue. Syngene will sell 2.2 crore equity shares. Post-offer, promoters’ stake would come down to 74.5 per cent from 85.5 per cent now. Analysts will be keenly watching the response to the public issue.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.